News / Events
Home/News/Events/News / Events/Congratulations! Approval was granted by TFDA for a phase II cell therapy clinical trial study

Congratulations! Approval was granted by TFDA for a phase II cell therapy clinical trial study

UPDATE : 2019/09/12
The VCRO's partner completed the phase I clinical trial and the trial report was successfully approved by TFDA recently. Congratulations to them, a phase II cell therapy clinical trial was granted by TFDA  on 2019/09/11. It was a phase II cell therapy drug trial for chronic stroke used for IND-registration. VCRO has been providing a full range of services in the field of cell therapy to help partners achieve new drug R&D milestones. Our partner have granted by the authorities and VCRO was deeply honored!

Reference
 
舞狮争霸走势图 售前工程师赚钱吗 极速快乐十分app 吉林十一选五 北单 大乐透短信投注方法 最好玩的街机捕鱼达人网页版 美宜佳到底赚不赚钱 广西11选5 365彩票官网 20选5 1378捕鱼作弊器 舟山体彩飞鱼开奖 陕西十一选五 足彩半全场彩票 湖北十一选五 极速11选5开奖官网